Interní Med. 2010; 12(4): 186-190
Early diagnostic of chronic obstructive pulmonary disease, therapy and their pharmacoeconomy profits
- Privátní plicní a praktický lékař, Neratovice
Chronic obstructive pulmonary disease (COPD) is currently the fourth cause of mortality in the world and it is predicted to rank third in
the year 2020. The prevalence of COPD varies in different regions of the world, but it affects at least 10 % of the adult population. Despite
being a chronic disease, that can not be cured, it is preventable disease (reducing tobacco consumption mostly) and treatable. We are
indeed capable to improve many manifestation of disease, including symptoms, exacerbations, health status and prognosis.
Keywords: COPD, diagnostic, therapy, exacerbation, farmacoeconomy
Published: May 1, 2010 Show citation
References
- Global Initiative for Chronic Obstructive Lung Disease, Global strategy for the diagnosis, management and prevention of COPD, 2006: 88 s.
- Kašák V, et al. Studie Burden (v tisku).
- Vondra V, Malý M. Dlouhodobé sledování ukazatelů hospitalizace pro CHOPN a astma v ČR. Lékařské listy, ZN, 2009; 9: 5-6.
- Beeh KM, et al. Study design considerations in large COPD trials comparing effects of tiotropium with salmeterol on exacerbations. International journal of COPD 2009; 4: 119-125.
Go to original source...